A Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblinded) Study to Investigate Protective Effects of GSK1278863 on Eccentric Exercise Induced Muscle Damage in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 12 May 2017
Price : $35 *
At a glance
- Drugs Daprodustat (Primary)
- Indications Tendon injuries
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 26 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 22 Feb 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 06 Jan 2015 Planned initiation date changed from 1 Dec 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.